Giuseppe Mancia is an expert in Cardiology at Ospedale Niguarda Ca' Granda (Italy). As of October 2026, ScienceLeadR ranks Giuseppe Mancia in the top 1% of experts worldwide for Reflex, Hypertension and Essential Hypertension. Giuseppe Mancia has authored 1,804 publications, the most recent in 2026, and is an investigator in 19 clinical trials. SLR score: 5,890 (community average: 125). How the SLR is computed.

LeadR Profile

Giuseppe Mancia Ospedale Niguarda Ca' Granda Italy
5 890 ScienceLeadR Reputation 5890
Network Map

Cardiology

Subspecialties: Hematology - Internal Medicine - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Giuseppe Mancia is Professor Emeritus at the University Milano-Bicocca, after serving for 20 years as Chairman of the Division and Department of Internal Medicine at the same University at the San Gerardo Hospital in Monza and Director of the Interuniversity (Universities of Milano, Milano-Bicocca, and Pavia) Center for Clinical Physiology and Hypertension. He was Chairman (2001, 2003, 2005, 2007, 2009, 2011, 2013, 2017 and 2023) of the Scientific and Organizing Committee of ESH meetings, and is a past President of the International Society of Hypertension (ISH), European Society of Hypertension (ESH), European Society of Clinical Investigation, and Italian Society of Hypertension. He chaired the Task Force of the ESH/ESC Hypertension Guidelines in 2003, 2007, 2009, 2013, 2018 and 2023. Professor Mancia is currently Chairman of the ESH Foundation. He is an honorary member of several hypertension and cardiovascular societies and has received many awards, including the Excellence Research Award of AHA, the Heymans Award of the International Society of Pharmacology, the Volhard and Tigersted Awards of the ISH, the Folkow Award of the ESH, the International Recordati Prize, the Invernizzi Prize for Medicine, the Spinoza Honorary Professorship of the University of Amsterdam, the Gold Medal of the Lorenzini Foundation, an Honorary Professorship of the University of Córdoba, an Honoris Causa Doctorate in Medicine from the University of Gdansk, Bucharest (Carol Davila), and Glasgow, the Hariri Memorial Lecture and Award, the MacDonald Award of McMaster University (Hamilton) and the Cleveland Clinic Lecture. Professor Mancia’s research focuses on the epidemiology, pathophysiology, diagnosis, and treatment of hypertension, heart failure, coronary and other cardiovascular diseases. He has edited more than 20 books on hypertension and cardiovascular diseases and published more than 2400 articles in peer review international journals. His articles have received more than 240,000 citations (H-index 182, Microsoft Academics, December 2021).He has been Deputy and Chief Editor of the Journal of Hypertension (1995-2021)


Organizations

Career arc: 1987 - 2026

Source: PubMed

Ospedale Niguarda Ca' Granda

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1804

Citations

Citations: 189 850 1st author: 302 Last author: 712 Unique author: 98


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Twenty-four-hour mean blood pressure and variability combined improve the prognostic value of ambulatory blood pressure.
PMID 42861788 — hypertension, mortality, blood, blood pressure, prognosis
J Hypertens20260
Real-world analysis of adherence, persistence, and outcomes in patients receiving four-drug antihypertensive therapy.
PMID 42736626 — hypertension, mortality, pharmaceutical preparations, drug therapy, antihypertensive agents, angiotensins, therapeutics, thiazides
Eur Heart J Cardiovasc Pharmacother20260
A 25-YEAR LONGITUDINAL GENDER-BASED STUDY ON LEFT VENTRICULAR GEOMETRY TRACKING IN THE GENERAL POPULATION: THE PAMELA STUDY.
PMID 42560849 — hypertension, aging, prevalence, sex
Am J Hypertens20260
Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study.
PMID 42538498 — hypertension, safety, antihypertensive agents, nebivolol, therapeutics, amlodipine
High Blood Press Cardiovasc Prev20260
The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts' Proposal.
PMID 42488774 — risk management, diagnosis, therapeutics
Eur Cardiol20261

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 8
N/A 5
Phase 4 4
Phase 2 2

By status:

Completed 16
Recruiting 2
Terminated 1

By type:

Interventional 16
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 3
multicentric5to9 2
multicentricup10 7

Main Topics

LeadR Networks

Main global connection map